Market Overview

UPDATE: Stifel Nicolaus Upgrades WebMD Health Corp to Buy Following Q4 Beat

Related WBMD
'Attractive Entry Points' In WebMD And Everyday Health Following Clinton's Sell-Off Plan
Benzinga's Top Upgrades

Stifel Nicolaus upgraded WebMD Health Corp (NASDAQ: WBMD) from Hold to Buy and announced a $26.00 price target.

Stifel Nicolaus commented, "We are upgrading shares of WebMD to Buy from Hold and establishing a $26 12-month price target, which is approximately 12.0x our 2014 adjusted EBITDA estimate of $90.2 million. We believe that pricing changes (greater choice and simplicity) implemented in 4Q12 suggest advertising trends are likely to improve. We expect traction in mobile to continue and provide a catalyst for a turnaround at WebMD."

WebMD Health Corp closed at $16.30 on Thursday.

Latest Ratings for WBMD

Sep 2015Cowen & CompanyUpgradesOutperform
Aug 2015SunTrust Robinson HumphreyUpgradesNeutralPositive
Jan 2015SunTrust Robinson HumphreyMaintainsNeutral

View More Analyst Ratings for WBMD
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Upgrades Analyst Ratings


Related Articles (WBMD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters